1.Clinical factors associated with composition of lung microbiota and important taxa predicting clinical prognosis in patients with severe community-acquired pneumonia.
Sisi DU ; Xiaojing WU ; Binbin LI ; Yimin WANG ; Lianhan SHANG ; Xu HUANG ; Yudi XIA ; Donghao YU ; Naicong LU ; Zhibo LIU ; Chunlei WANG ; Xinmeng LIU ; Zhujia XIONG ; Xiaohui ZOU ; Binghuai LU ; Yingmei LIU ; Qingyuan ZHAN ; Bin CAO
Frontiers of Medicine 2022;16(3):389-402
Few studies have described the key features and prognostic roles of lung microbiota in patients with severe community-acquired pneumonia (SCAP). We prospectively enrolled consecutive SCAP patients admitted to ICU. Bronchoscopy was performed at bedside within 48 h of ICU admission, and 16S rRNA gene sequencing was applied to the collected bronchoalveolar lavage fluid. The primary outcome was clinical improvements defined as a decrease of 2 categories and above on a 7-category ordinal scale within 14 days following bronchoscopy. Sixty-seven patients were included. Multivariable permutational multivariate analysis of variance found that positive bacteria lab test results had the strongest independent association with lung microbiota (R2 = 0.033; P = 0.018), followed by acute kidney injury (AKI; R2 = 0.032; P = 0.011) and plasma MIP-1β level (R2 = 0.027; P = 0.044). Random forest identified that the families Prevotellaceae, Moraxellaceae, and Staphylococcaceae were the biomarkers related to the positive bacteria lab test results. Multivariable Cox regression showed that the increase in α-diversity and the abundance of the families Prevotellaceae and Actinomycetaceae were associated with clinical improvements. The positive bacteria lab test results, AKI, and plasma MIP-1β level were associated with patients' lung microbiota composition on ICU admission. The families Prevotellaceae and Actinomycetaceae on admission predicted clinical improvements.
Acute Kidney Injury/complications*
;
Bacteria/classification*
;
Chemokine CCL4/blood*
;
Community-Acquired Infections/microbiology*
;
Humans
;
Lung
;
Microbiota/genetics*
;
Pneumonia, Bacterial/diagnosis*
;
Prognosis
;
RNA, Ribosomal, 16S/genetics*
2.Evaluation of clinical usefulness of pneumococcal urinary antigen test: single center experience
In A PARK ; Eun Mi HAM ; Chang Hae PYO ; Sang Hyun PARK ; Keun Hong PARK ; Hahn Bom KIM ; Sang Hee OH
Journal of the Korean Society of Emergency Medicine 2019;30(3):273-280
OBJECTIVE: A pneumococcal urinary antigen (PUA) test, which can be performed quickly and easily, is performed frequently in emergency rooms because of its high sensitivity and specificity. On the other hand, it is a relatively expensive test, and it is not known how it affects the clinicians' prescription of antibiotics. This study evaluated the clinical utility of the PUA test. METHODS: This study was conducted retrospectively on patients aged ≥18 years, who underwent a PUA test and were hospitalized with a diagnosis of pneumonia in an emergency room from January to December 2016. The patients were divided into a PUA test positive group and negative group, and the clinical characteristics and antibiotic regimen were compared. RESULTS: A total of 533 patients were enrolled, of which 54 were positive and 479 were negative. The antibiotic prescriptions were similar in the positive and negative groups. After the PUA test result, only two of the positive group used the antibiotics recommended by the Infectious Diseases Society of America and the American Thoracic Society for Streptococcus pneumoniae. Furthermore, there was an appropriate change in eight patients after the blood culture test, but the PUA test result was judged to be meaningful in only two patients. CONCLUSION: The results of the PUA test did not affect the clinician's antibiotic prescription significantly. A prescription standard for the PUA test is needed, and it should be performed after admission rather than in the emergency room.
Americas
;
Anti-Bacterial Agents
;
Communicable Diseases
;
Diagnosis
;
Emergency Service, Hospital
;
Hand
;
Humans
;
Pneumonia
;
Prescriptions
;
Retrospective Studies
;
Sensitivity and Specificity
;
Streptococcus pneumoniae
3.A case of acute skin failure misdiagnosed as a pressure ulcer, leading to a legal dispute
Jung Hwan KIM ; Hea Kyeong SHIN ; Gyu Yong JUNG ; Dong Lark LEE
Archives of Plastic Surgery 2019;46(1):75-78
It is difficult to differentiate acute skin failure (ASF) from pressure ulcer (PU). ASF is defined as unavoidable injury resulting from hypoperfusion caused by severe dysfunction of another organ system. We describe a case of ASF mistaken as PU that resulted in a legal dispute. A 74-year-old male patient was admitted to our intensive care unit with sepsis due to bacterial pneumonia. Despite the use of air cushions and regular position changes, skin ulcerations occurred over his occiput, back, buttock, elbow, and ankle. After improvement in his general condition, he was transferred to the department of plastic and reconstructive surgery. Debridement was performed immediately, followed by conservative treatment (including a vacuum-assisted closure device) for 6 weeks. The buttock and occiput wounds were treated surgically. Despite complete healing, his caregivers sued the hospital for failing to prevent PU formation. ASF is a pressure-related injury resulting from hemodynamic instability due to organ system failure. Unlike PU, ASF may occur despite the implementation of all appropriate preventive measures. Furthermore, misdiagnosis of ASF as PU can lead to litigation. Therefore, it is critical for the proper diagnosis to be made quickly, and for physicians to explain that ASF occurs despite proper preventative treatment.
Aged
;
Ankle
;
Buttocks
;
Caregivers
;
Debridement
;
Diagnosis
;
Diagnostic Errors
;
Dissent and Disputes
;
Elbow
;
Hemodynamics
;
Humans
;
Intensive Care Units
;
Jurisprudence
;
Male
;
Necrosis
;
Negative-Pressure Wound Therapy
;
Plastics
;
Pneumonia, Bacterial
;
Pressure Ulcer
;
Sepsis
;
Skin Ulcer
;
Skin
;
Wounds and Injuries
4.Exogenous lipoid pneumonia presented by acute eosinophilic pneumonia.
Allergy, Asthma & Respiratory Disease 2019;7(1):57-60
Exogenous lipoid pneumonia is an uncommon medical condition resulting from aspiration or inhalation of oily material. Generally, lipoid pneumonia has nonspecific clinical and radiological presentations, and may be misdiagnosed as bacterial pneumonia or lung cancer. We describe an unusual case of exogenous lipoid pneumonia accompanied by peripheral blood and pulmonary eosinophilia. A 63-year-old man was admitted with progressively worsening exertional dyspnea and productive cough for 5 days. A chest radiograph showed abnormalities in the lower lobe of the right lung, and a diagnosis of community-acquired pneumonia was made; intravenous antibiotics were administered. However, dyspnea and hypoxia gradually worsened and peripheral blood eosinophilia developed. A bronchoscopy was performed and bronchoalveolar lavage fluid analysis showed markedly increased numbers of eosinophils (40%). Subsequently, a comprehensive review of history revealed that he fell asleep with camellia oil in his mouth for 2 weeks to relieve foreign body sensation of the throat. Sputum and bronchoalveolar lavage fluid cytology showed the presence of lipid-laden macrophages. He was diagnosed with lipoid pneumonia and acute eosinophilic pneumonia. Chest radiograph and symptom were rapidly improved after treatment with intravenous methylprednisolone.
Anoxia
;
Anti-Bacterial Agents
;
Bronchoalveolar Lavage Fluid
;
Bronchoscopy
;
Camellia
;
Cough
;
Diagnosis
;
Dyspnea
;
Eosinophilia
;
Eosinophils*
;
Foreign Bodies
;
Humans
;
Inhalation
;
Lung
;
Lung Neoplasms
;
Macrophages
;
Methylprednisolone
;
Middle Aged
;
Mouth
;
Pharynx
;
Pneumonia*
;
Pneumonia, Bacterial
;
Pneumonia, Lipid
;
Pulmonary Eosinophilia*
;
Radiography, Thoracic
;
Respiratory Aspiration
;
Sensation
;
Sputum
5.Simultaneous Diagnosis of Pneumococcal Sepsis and Disseminated Mycobacterium avium Complex Infection in a Patient with Acquired Immunodeficiency Syndrome.
Chang In NOH ; Miri HYUN ; Ji Yeon LEE ; Hyun Ah KIM ; Seong Yeol RYU
Korean Journal of Medicine 2017;92(1):89-93
The incidence of bacteremia in human immunodeficiency virus (HIV)-infected patients is significantly decreased by highly active antiretroviral therapy (HAART). However, bacteremia remains a major cause of morbidity and mortality in HIV-infected patients. A 43-year-old male who had fever and cough for 1 week presented to the emergency room. He was diagnosed with acquired immunodeficiency syndrome combined with atypical pneumonia and started on antibiotics plus HAART. After 3 days, Streptococcus pneumoniae was grown in blood cultures. Three weeks later, acid-fast bacilli cultures of blood and bronchoalveolar lavage fluid grew Mycobacterium avium complex (MAC); hence, the patient was treated with antimycobacterial drugs. HIV-infected patients with persistent fever despite administration of appropriate antibiotics should be examined for simultaneous infection by other organisms, such as nontuberculous mycobacteria. We report a case of simultaneous detection of MAC and S. pneumoniae in the blood of a treatment-naïve HIV-infected patient.
Acquired Immunodeficiency Syndrome*
;
Adult
;
Anti-Bacterial Agents
;
Antiretroviral Therapy, Highly Active
;
Bacteremia
;
Bronchoalveolar Lavage Fluid
;
Cough
;
Diagnosis*
;
Emergency Service, Hospital
;
Fever
;
HIV
;
Humans
;
Incidence
;
Male
;
Mortality
;
Mycobacterium avium Complex*
;
Mycobacterium avium*
;
Mycobacterium*
;
Nontuberculous Mycobacteria
;
Pneumonia
;
Sepsis*
;
Streptococcus pneumoniae
6.¹⁸F-FDG PET/CT for the Diagnosis of Malignant and Infectious Complications After Solid Organ Transplantation
Nastassja MULLER ; Romain KESSLER ; Sophie CAILLARD ; Eric EPAILLY ; Fabrice HUBELÉ ; Céline HEIMBURGER ; Izzie Jacques NAMER ; Raoul HERBRECHT ; Cyrille BLONDET ; Alessio IMPERIALE
Nuclear Medicine and Molecular Imaging 2017;51(1):58-68
PURPOSE: Infection and malignancy represent two common complications after solid organ transplantation, which are often characterized by poorly specific clinical symptomatology. Herein, we have evaluated the role of 18F-fluoro-2-deoxy-Dglucose (FDG) positron emission tomography/computed tomography (PET/CT) in this clinical setting.METHODS: Fifty-eight consecutive patients who underwent FDG PET/CT after kidney, lung or heart transplantation were included in this retrospective analysis. Twelve patients underwent FDGPET/CT to strengthen or confirma diagnostic suspicion of malignancies. The remaining 46 patients presented with unexplained inflammatory syndrome, fever of unknown origin (FUO), CMVor EBV seroconversion during post-transplant follow-up without conclusive conventional imaging. FDG PET/CT results were compared to histology or to the finding obtained during a clinical/imaging follow-up period of at least 6 months after PET/CT study.RESULTS: Positive FDG PET/CT results were obtained in 18 (31 %) patients. In the remaining 40 (69 %) cases, FDG PET/CT was negative, showing exclusively a physiological radiotracer distribution. On the basis of a patient-based analysis, FDG PET/CT's sensitivity, specificity, PPV and NPV were respectively 78 %, 90 %, 78 % and 90 %, with a global accuracy of 86 %. FDG PET/CT was true positive in 14 patients with bacterial pneumonias (n = 4), pulmonary fungal infection (n = 1), histoplasmosis (n = 1), cutaneous abscess (n = 1), inflammatory disorder (sacroiliitis) (n = 1), lymphoma (n = 3) and NSCLC (n = 3). On the other hand, FDG PET/CT failed to detect lung bronchoalveolar adenocarcinoma, septicemia, endocarditis and graft-versus-host disease (GVHD), respectively, in four patients. FDG PET/CT contributed to adjusting the patient therapeutic strategy in 40 % of cases.CONCLUSIONS: FDG PET/CT emerges as a valuable technique to manage complications in the post-transplantation period. FDG PET/CT should be considered in patients with severe unexplained inflammatory syndrome or FUO and inconclusive conventional imaging or to discriminate active from silent lesions previously detected by conventional imaging particularly when malignancy is suspected.
Abscess
;
Adenocarcinoma
;
Diagnosis
;
Electrons
;
Endocarditis
;
Fever of Unknown Origin
;
Follow-Up Studies
;
Graft vs Host Disease
;
Hand
;
Heart Transplantation
;
Herpesvirus 4, Human
;
Histoplasmosis
;
Humans
;
Kidney
;
Lung
;
Lung Diseases, Fungal
;
Lymphoma
;
Organ Transplantation
;
Pneumonia, Bacterial
;
Positron-Emission Tomography and Computed Tomography
;
Retrospective Studies
;
Sensitivity and Specificity
;
Sepsis
;
Seroconversion
;
Transplants
7.Facility characteristics as independent prognostic factors of nursing home-acquired pneumonia.
Che Wan LIM ; Younghoon CHOI ; Chang Hyeok AN ; Sang Joon PARK ; Hee Jin HWANG ; Jae Ho CHUNG ; Joo Won MIN
The Korean Journal of Internal Medicine 2016;31(2):296-304
BACKGROUND/AIMS: Recently, the incidence of nursing home-acquired pneumonia (NHAP) has been increasing and is now the leading cause of death among nursing home residents. This study was performed to identify risk factors associated with NHAP mortality, focusing on facility characteristics. METHODS: Data on all patients > or = 70 years of age admitted with newly diagnosed pneumonia were reviewed. To compare the quality of care in nursing facilities, the following three groups were defined: patients who acquired pneumonia in the community, care homes, and care hospitals. In these patients, 90-day mortality was compared. RESULTS: Survival analyses were performed in 282 patients with pneumonia. In the analyses, 90-day mortality was higher in patients in care homes (12.2%, 40.3%, and 19.6% in community, care homes, and care hospitals, respectively). Among the 118 NHAP patients, residence in a care home, structural lung diseases, treatment with inappropriate antimicrobial agents for accompanying infections, and a high pneumonia severity index score were risk factors associated with higher 90-day mortality. However, infection by potentially drug-resistant pathogens was not important. CONCLUSIONS: Unfavorable institutional factors in care homes are important prognostic factors for NHAP.
Aged
;
Aged, 80 and over
;
Anti-Bacterial Agents/therapeutic use
;
Cause of Death
;
Cross Infection/diagnosis/drug therapy/microbiology/*mortality
;
Female
;
*Homes for the Aged
;
*Hospitals
;
Humans
;
Inappropriate Prescribing
;
Kaplan-Meier Estimate
;
Male
;
*Nursing Homes
;
Pneumonia, Bacterial/diagnosis/drug therapy/microbiology/*mortality
;
Proportional Hazards Models
;
Retrospective Studies
;
Risk Factors
;
Time Factors
;
Treatment Outcome
10.Application of Mycoplasma pneumoniae antibody and load index in the diagnosis of Mycoplasma pneumoniae pneumonia in children.
Hui XIE ; Ji-Ming LI ; Hui-Fen ZHANG ; Ye WANG ; Li-Lin ZHONG ; Qing-Rong LIAN ; Hong-Ba DONG
Chinese Journal of Contemporary Pediatrics 2016;18(10):984-987
OBJECTIVETo study the role of Mycoplasma pneumoniae (MP) load and antibody measurements in the diagnosis of MP pneumonia.
METHODSA total of 115 children with MP pneumonia and 400 healthy children were enrolled. The MP load and total antibody level were measured at different stages, and the MP load index (MPLI) was calculated.
RESULTSThe cut-off value of MPLI for MP infection was 6.12. MPLI and total antibody titer increased during the course of the disease, while MP-DNA decreased rapidly. Within the same time of blood collection, the group with a higher MP load had a significantly higher total antibody titer than the group with a lower MP load (P<0.05). Within 2 weeks of the course of the disease, the negative antibody group had a significantly higher MPLI than the positive antibody group (P<0.05).
CONCLUSIONSMPLI provides a standardized quantitative value of MP-DNA and plays an important role in the early diagnosis of MP infection.
Antibodies, Bacterial ; blood ; Child ; Child, Preschool ; DNA, Bacterial ; analysis ; Early Diagnosis ; Female ; Humans ; Infant ; Male ; Pneumonia, Mycoplasma ; diagnosis ; microbiology

Result Analysis
Print
Save
E-mail